日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Colorectal cancer pathogenesis, oncogenic signaling networks and targeted therapeutic advances

结直肠癌的发病机制、致癌信号网络和靶向治疗进展

Chen, Yue; Zhang, Jiaqi; Ding, Yi; Zhu, Fang; Chen, Yinnan

Extrachromosomal circular DNA as a novel biomarker for the progression of colorectal cancer

染色体外环状DNA作为结直肠癌进展的新型生物标志物

Qiu, Quanpeng; Ding, Yi; Guo, Xiaolong; Han, Jing; Zhang, Jiaqi; Liu, Yaping; She, Junjun; Chen, Yinnan

Correction: Qiu et al. P53 Deficiency Accelerates Esophageal Epithelium Intestinal Metaplasia Malignancy. Biomedicines 2023, 11, 882

更正:Qiu 等人,《P53 缺陷加速食管上皮肠化生恶性肿瘤》,《生物医学》2023,11,882

Qiu, Quanpeng; Guo, Gang; Guo, Xiaolong; Hu, Xiake; Yu, Tianyu; Liu, Gaixia; Zhang, Haowei; Chen, Yinnan; She, Junjun

MGMT activated by Wnt pathway promotes cisplatin tolerance through inducing slow-cycling cells and nonhomologous end joining in colorectal cancer.

Wnt 通路激活的 MGMT 通过诱导结直肠癌细胞的慢周期性增殖和非同源末端连接来促进顺铂耐受性

Zhang Haowei, Li Qixin, Guo Xiaolong, Wu Hong, Hu Chenhao, Liu Gaixia, Yu Tianyu, Hu Xiake, Qiu Quanpeng, Guo Gang, She Junjun, Chen Yinnan

Chemokine family significance and prognostic value in colorectal cancer.

趋化因子家族在结直肠癌中的意义和预后价值

Ding Yi, Chen Yinnan, Xie Siyun, Qiu Quanpeng, Guo Xiaolong, Feng Yun, Li Hongxia, Zhu Fang, Liu Yaping

Establish a novel tumor budding-related signature to predict prognosis and guide clinical therapy in colorectal cancer

建立一种新的肿瘤出芽相关特征,用于预测结直肠癌的预后并指导临床治疗

Li, Qixin; Liu, Gaixia; Qiu, Quanpeng; Zhang, Jiaqi; Li, Ruizhe; Zhao, Jiamian; She, Junjun; Chen, Yinnan

Altered gut microbiome composition by appendectomy contributes to colorectal cancer

阑尾切除术引起的肠道菌群组成改变是结直肠癌的致病因素之一。

Shi, Feiyu; Liu, Gaixia; Lin, Yufeng; Guo, Cosmos Liutao; Han, Jing; Chu, Eagle S H; Shi, Chengxin; Li, Yaguang; Zhang, Haowei; Hu, Chenhao; Liu, Ruihan; He, Shuixiang; Guo, Gang; Chen, Yinnan; Zhang, Xiang; Coker, Olabisi Oluwabukola; Wong, Sunny Hei; Yu, Jun; She, Junjun

Extrachromosomal circular DNA in colorectal cancer: biogenesis, function and potential as therapeutic target

结直肠癌中的染色体外环状DNA:生物发生、功能及其作为治疗靶点的潜力

Chen, Yinnan; Qiu, Quanpeng; She, Junjun; Yu, Jun

Reduced PHLPP Expression Leads to EGFR-TKI Resistance in Lung Cancer by Activating PI3K-AKT and MAPK-ERK Dual Signaling

PHLPP 表达降低通过激活 PI3K-AKT 和 MAPK-ERK 双信号传导导致肺癌产生 EGFR-TKI 耐药

Wei Wang, Xinhang Xia, Kuifei Chen, Meng Chen, Yinnan Meng, Dongqing Lv, Haihua Yang

Application of the CRISPR/Cas9 System to Drug Resistance in Breast Cancer

CRISPR/Cas9系统在乳腺癌耐药性研究中的应用

Chen, Yinnan; Zhang, Yanmin